ConductScience.org, home

Trial · NCT01968967

Registered outcomes31

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPercent Change From Baseline in Fasting Low Density Lipoprotein Cholesterol (LDL-C) at Week 12Baseline, Week 12
SecondaryPercent Change From Baseline in Fasting Total Cholesterol (TC) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting Apolipoprotein B (ApoB) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting Non High Density Lipoprotein Cholesterol (HDL-C) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting Low Density Lipoprotein Cholesterol (LDL-C) by Triglycerides (TG) Cut-off of Less Than (<) 200 Milligram Per Deciliter (mg/dL) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting Low Density Lipoprotein Cholesterol (LDL-C) by Triglycerides Cut-off of Greater Than or Equal to (>=) 200 Milligram Per Deciliter (mg/dL) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting Lipoprotein (a) (Lp[a]) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting High Density Lipoprotein Cholesterol (HDL-C) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting Low Density Lipoprotein Cholesterol (LDL-C) at Week 24, 52: Treatment PeriodBaseline, Week 24, 52
SecondaryPercent Change From Baseline in Fasting Triglycerides (TG) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting Apolipoprotein A-I (ApoA-I) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting Apolipoprotein A-II (ApoA-II) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryPercent Change From Baseline in Fasting Very Low Density Lipoprotein Cholesterol (VLDL-C) at Week 12, 24 and 52Baseline, Week 12, 24, 52
SecondaryAbsolute Change From Baseline in Fasting Low Density Lipoprotein Cholesterol (LDL-C) by Triglycerides Cut-off of Less Than (<) 200 Milligram Per Deciliter (mg/dL) at Week 12Baseline, Week 12
SecondaryAbsolute Change From Baseline in Fasting Low Density Lipoprotein Cholesterol (LDL-C) by Triglycerides Cut-off of Greater Than or Equal to (>=) 200 Milligram Per Deciliter (mg/dL) at Week 12Baseline, Week 12
SecondaryAbsolute Change From Baseline in Fasting Low Density Lipoprotein Cholesterol (LDL-C) at Week 12Baseline, Week 12
SecondaryAbsolute Change From Baseline in Fasting Total Cholesterol (TC) at Week 12Baseline, Week 12
SecondaryAbsolute Change From Baseline in Fasting Non High Density Lipoprotein Cholesterol (HDL-C) at Week 12Baseline, Week 12
SecondaryAbsolute Change From Baseline in Fasting Apolipoprotein B (ApoB) at Week 12Baseline, Week 12
SecondaryAbsolute Change From Baseline in Fasting Lipoprotein (a) (Lp[a]) at Week 12Baseline, Week 12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01968967/registered